IL6 and preterm premature rupture of the membranes: According to our findings, CVF IL-6 could serve as a point-of-care (POC) test to stratify risk in women with PPROM for the outcome of HCA, having an excellent sensitivity and a great diagnostic performance (AUC 0.91) for this subgroup.